These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16304483)

  • 1. Brain tumor enhancement in magnetic resonance imaging: comparison of signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) at 1.5 versus 3 tesla.
    Biswas J; Nelson CB; Runge VM; Wintersperger BJ; Baumann SS; Jackson CB; Patel T
    Invest Radiol; 2005 Dec; 40(12):792-7. PubMed ID: 16304483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain tumor enhancement in MR imaging at 3 Tesla: comparison of SNR and CNR gain using TSE and GRE techniques.
    Wintersperger BJ; Runge VM; Biswas J; Reiser MF; Schoenberg SO
    Invest Radiol; 2007 Aug; 42(8):558-63. PubMed ID: 17620938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of gadobenate dimeglumine (Gd-BOPTA) at 3 Tesla in brain magnetic resonance imaging: comparison to 1.5 Tesla and a standard gadolinium chelate using a rat brain tumor model.
    Runge VM; Biswas J; Wintersperger BJ; Baumann SS; Jackson CB; Herborn CU; Patel T
    Invest Radiol; 2006 Mar; 41(3):244-8. PubMed ID: 16481906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of lesion enhancement using 1 M gadobutrol vs. 2 conventional gadolinium chelates, all at a dose of 0.1 mmol/kg, in a rat brain tumor model at 3 T.
    Attenberger UI; Runge VM; Jackson CB; Baumann S; Birkemeier K; Michaely HJ; Schoenberg SO; Reiser MF; Wintersperger BJ
    Invest Radiol; 2009 May; 44(5):251-6. PubMed ID: 19550376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain tumor enhancement in magnetic resonance imaging: dependency on the level of protein binding of applied contrast agents.
    Wintersperger BJ; Runge VM; Tweedle MF; Jackson CB; Reiser MF
    Invest Radiol; 2009 Feb; 44(2):89-94. PubMed ID: 19077910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
    Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
    Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of gadobutrol, a macrocyclic, nonionic gadolinium chelate in a brain glioma model: comparison with gadoterate meglumine and gadopentetate dimeglumine at 1.5 T, combined with an assessment of field strength dependence, specifically 1.5 versus 3 T.
    Attenberger UI; Runge VM; Morelli JN; Williams J; Jackson CB; Michaely HJ
    J Magn Reson Imaging; 2010 Mar; 31(3):549-55. PubMed ID: 20187196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of gadodiamide versus gadobutrol for contrast-enhanced MR imaging in a rat brain glioma model at 1.5 and 3 T.
    Morelli JN; Runge VM; Vu L; Loynachan AT; Attenberger UI
    Invest Radiol; 2010 Dec; 45(12):810-8. PubMed ID: 20856127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic contrast enhancement of experimental glioma an intra-individual comparative study to assess the optimal time delay.
    Engelhorn T; Schwarz MA; Eyupoglu IY; Kloska SP; Struffert T; Doerfler A
    Acad Radiol; 2010 Feb; 17(2):188-93. PubMed ID: 19910218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement in a brain glioma model: a comparison of half-dose gadobenate dimeglumine versus full-dose gadopentetate dimeglumine at 1.5 and 3 T.
    Morelli JN; Gerdes CM; Zhang W; Williams JM; Saettele MR; Ai F
    J Magn Reson Imaging; 2013 Aug; 38(2):306-11. PubMed ID: 23737259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T1-weighted imaging of the brain at 3 tesla using a 2-dimensional spoiled gradient echo technique.
    Runge VM; Patel MC; Baumann SS; Simonetta AB; Ponzo JA; Lesley WS; Calderwood GW; Naul LG
    Invest Radiol; 2006 Feb; 41(2):68-75. PubMed ID: 16428975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of gadobutrol versus gadopentetate dimeglumine in enhanced MRI of brain metastases.
    Fan B; Li M; Wang X; Xu Y; Li F; Zhang L; Jiang J; Jiang Y
    J Magn Reson Imaging; 2017 Jun; 45(6):1827-1834. PubMed ID: 27696616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of a T1-weighted inversion-recovery-, gradient-echo- and spin-echo sequence for imaging of the brain at 3.0 Tesla].
    Stehling C; Niederstadt T; Krämer S; Kugel H; Schwindt W; Heindel W; Bachmann R
    Rofo; 2005 Apr; 177(4):536-42. PubMed ID: 15838759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a fibrin-binding gadolinium chelate peptide tetramer in a brain glioma model.
    Morelli JN; Runge VM; Williams JM; Beissner RS; Tweedle M
    Invest Radiol; 2011 Mar; 46(3):169-77. PubMed ID: 21150792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic abscesses. Magnetic resonance imaging findings using gadolinium-BOPTA.
    Runge VM; Wells JW; Williams NM
    Invest Radiol; 1996 Dec; 31(12):781-8. PubMed ID: 8970881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain MRI with single-dose (0.1 mmol/kg) Gadobutrol at 1.5 T and 3 T: comparison with 0.15 mmol/kg Gadoterate meglumine.
    Kramer H; Runge VM; Naul LG; Loynachan AT; Reiser MF; Wintersperger BJ
    AJR Am J Roentgenol; 2010 May; 194(5):1337-42. PubMed ID: 20410423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved visibility of brain tumors in synthetic MP-RAGE anatomies with pure T1 weighting.
    Nöth U; Hattingen E; Bähr O; Tichy J; Deichmann R
    NMR Biomed; 2015 Jul; 28(7):818-30. PubMed ID: 25960356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of myocardial viability using delayed enhancement magnetic resonance imaging at 3.0 Tesla.
    Klumpp B; Fenchel M; Hoevelborn T; Helber U; Scheule A; Claussen C; Miller S
    Invest Radiol; 2006 Sep; 41(9):661-7. PubMed ID: 16896300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Gd-DTPA-induced signal enhancements in rat brain C6 glioma among different pulse sequences in 3-Tesla magnetic resonance imaging.
    Sato H; Enmi J; Teramoto N; Hayashi T; Yamamoto A; Tsuji T; Naito H; Iida H
    Acta Radiol; 2008 Mar; 49(2):172-9. PubMed ID: 18300142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas.
    Fayed N; Morales H; Modrego PJ; Pina MA
    Acad Radiol; 2006 Jun; 13(6):728-37. PubMed ID: 16679275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.